The Brief Psychiatric Rating Scale, 18-item version (BPRS-18) is a clinician-rated instrument assessing the severity of positive, negative and affective symptoms in psychotic disorders, especially schizophrenia. Unlike a self-report screener, every item is a clinical judgement made by the rater following an interview and observation. Its main use is tracking a single patient's symptom severity across repeat administrations, not classifying a person against a population norm. This guide covers what the BPRS-18 measures, exactly how its 0-7 item scale works, why no cut-off is published, and where it fits alongside PANSS.
What the BPRS-18 measures
The BPRS-18 is completed by a clinician, typically taking around 25 minutes, and assesses positive symptoms (such as unusual thought content and hallucinatory behavior), negative symptoms (such as blunted affect and emotional withdrawal), and affective symptoms across 18 clinically defined constructs. It is intended for adults and is most often used in the assessment and ongoing monitoring of schizophrenia and other psychotic disorders, including tracking how symptoms change over the course of treatment.
The 18 items and rating scale
Each of the 18 items is rated by the clinician on an eight-point scale:
- 0 - Not assessed
- 1 - Not present
- 2 - Very mild
- 3 - Mild
- 4 - Moderate
- 5 - Moderately severe
- 6 - Severe
- 7 - Extremely severe
The inclusion of a distinct "0 - Not assessed" code, separate from "1 - Not present," is a deliberate design feature: it lets the rater record that a particular symptom construct genuinely could not be evaluated during that session (for example, if the patient was unable to engage with a relevant line of questioning), rather than forcing a false "not present" rating that would understate genuine uncertainty in the record.
How to score the BPRS-18
The 18 item ratings are summed to produce a total ranging from 0 to 126. Because each item carries real clinical meaning at every point on its 0-7 scale, and because the "not assessed" code needs to be handled deliberately rather than accidentally treated as a zero-severity rating, consistent scoring across repeat administrations benefits from automated scoring that totals the same way every time a clinician completes the form.
Why there is no published BPRS-18 cut-off
Clinicians new to the BPRS-18 sometimes look for a severity band the way they would with a self-report screener - a "mild/moderate/severe" cut-off table. None exists for the BPRS-18, and this is deliberate rather than a gap in this guide: the total is intended to be compared across serial administrations of the same patient to track response to treatment, not classified against a population norm. In other words, the BPRS-18's clinical value comes from watching one patient's total (and individual item ratings) move over successive assessments during a course of treatment, not from asking whether a single score at one point in time crosses a fixed threshold.
Who completes it, age range, and time required
The BPRS-18 is completed by a clinician, based on a structured interview and observation of the patient, and is intended for adults. A full administration takes approximately 25 minutes.
BPRS-18 compared with PANSS
The BPRS-18 is frequently discussed alongside the Positive and Negative Syndrome Scale (PANSS), and clinicians often ask which to use. Both are clinician-rated instruments assessing symptom severity in psychotic disorders through interview and observation rather than self-report - reflecting the reality that acute psychotic symptoms often cannot be reliably captured through self-report alone. The practical difference is scope and item count: the BPRS-18 covers 18 constructs on a 0-7 scale for a total range of 0-126, while PANSS covers 30 items structured around positive, negative and general psychopathology domains. Broadly, the BPRS-18 is the shorter of the two, which matters when repeat administrations are needed frequently to track treatment response, while PANSS's larger item set is often chosen when a more granular symptom-domain breakdown is the priority. Neither instrument replaces full clinical interview and history in reaching a diagnosis.
Limitations
As a clinician-rated instrument, the BPRS-18 depends on the rater's training and judgement, which introduces the possibility of inter-rater variability - two clinicians observing the same patient may not always rate every item identically, which is why familiarity with the anchor definitions for each severity level matters. Because no population-referenced cut-off is published, the BPRS-18 cannot answer "is this patient's symptom level abnormal" in isolation; it can only answer "has this patient's symptom level changed" when compared against their own earlier administrations. It is a rating scale, not a diagnostic instrument, and should always be used within a full clinical assessment.
Using the BPRS-18 digitally
A digital BPRS-18 form lets the clinician record each of the 18 item ratings during or immediately after the interview, calculates the total instantly, and stores each administration so successive totals and item-level ratings can be compared directly - which is exactly how the instrument is intended to be used, as a longitudinal tracking tool rather than a one-off classification. This supports measurement-based care in ongoing psychosis treatment.
Key takeaways
- The BPRS-18 is an 18-item clinician-rated scale assessing positive, negative and affective symptoms in psychotic disorders.
- Each item is rated 0 (Not assessed) to 7 (Extremely severe); the total ranges from 0 to 126.
- No severity cut-off is published - the total is meant to be compared across serial administrations of the same patient to track treatment response.
- It is completed by a clinician following a structured interview, taking about 25 minutes, in adults.
- The BPRS-18 (18 items, 0-126) is shorter than PANSS (30 items), which is one reason it is often chosen for frequent repeat tracking.
Frequently Asked Questions
See LetPsyc in your own practice
Digital psychological assessments, automatic scoring, and clinician-grade PDF reports — built for clinicians across Pakistan and beyond. Start your free trial today.
Start Free Trial